首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Follow up of patients with ocular scarring secondary to LOC syndrome treated by amniotic membrane transplantation
【2h】

Follow up of patients with ocular scarring secondary to LOC syndrome treated by amniotic membrane transplantation

机译:羊膜移植治疗LOC综合征继发性眼部瘢痕患者的随访

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aims: To document and discuss the long term outcome of a new ophthalmic treatment for laryngo-onycho-cutaneous (LOC) syndrome.>Methods: Two children were treated by excision of ocular granulation tissue and ocular surface rehabilitation with frozen amniotic membrane (AM). The clinical course of both patients was followed and documented at 2 years and 4 years following the surgery.>Results: Patient 1 demonstrated limited recurrence of granulation tissue at 10 months. After 36 months, re-growth of granulation and scar tissue required a further three subsequent operations to the right eye in an attempt to keep the optical axis clear. 4 years postoperatively, neither eye has a clear visual axis. In contrast similar surgery for the right eye of patient 2 has been highly successful, with only very limited non-progressive recurrence after 2 years of follow up. The operation to the left eye has been similarly effective although the follow up is only 6 months.>Conclusions: Ocular surface rehabilitation with AM is the first partially effective treatment for the eye complications of LOC syndrome. The surprising benefit from AM may stem from the primary pathology of the condition. LOC syndrome is caused by a genetic defect resulting in an unusual N-terminal deletion of the α3a chain of the basement membrane protein laminin 5. One mechanism through which AM transplantation may act to reduce ocular scarring in this disease is to supplement the abnormal secreted laminin 5 with healthy transplanted laminin. Despite its initial efficacy one episode of AM treatment does not guarantee long term control of the scarring process and variations in AM graft efficacy may be related to other complicating factors such as limbal stem cell deficiency or severity of the initial scarring process.
机译:>目的:记录和讨论一种新的眼科治疗喉头-皮肤-皮肤综合征(LOC)综合征的长期治疗方法。>方法:冷冻羊膜(AM)肉芽组织和眼表修复。随访两名患者的临床病程,并在术后2年和4年记录。>结果:患者1在10个月时肉芽组织复发有限。 36个月后,肉芽和疤痕组织的重新生长需要右眼再进行三次后续手术,以保持光轴通畅。术后4年,两只眼睛的视轴都不清晰。相反,对患者2的右眼进行的类似手术非常成功,在随访2年后仅有非常有限的非进行性复发。尽管随访仅6个月,但对左眼的手术也取得了类似的效果。>结论: AM的眼表康复是首例对LOC综合征眼部并发症有效的部分治疗方法。 AM带来的令人惊讶的好处可能来自于疾病的主要病理。 LOC综合征是由遗传缺陷引起的,该缺陷导致基底膜蛋白层粘连蛋白5的N3a链异常N端缺失。AM移植可减少这种疾病的眼部瘢痕形成的一种机制是补充异常分泌的层粘连蛋白。 5用健康的层粘连蛋白移植。尽管其具有最初的疗效,但一次AM治疗并不能保证瘢痕形成过程的长期控制,并且AM移植功效的变化可能与其他复杂因素有关,例如角膜缘干细胞缺乏或初始瘢痕形成过程的严重性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号